Different Hemostatic Agents Used in Partial Pulpotomy on Pulp Survival and Postoperative Pain
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Sodium Hypochlorite 2,5%, Chlorhexidine, Cold Saline.
- Who it may be relevant to
- Registry conditions: Efficacy of Hemostatic Agents, Partial Pulpotomy, Postoperative Pain. Basic parameters: 15 years — 55 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Effect of Different Hemostatic Agents Used in Partial Pulpotomy on Pulp Survival and Postoperative Pain: A Randomized Clinical Trial
Overview
This randomized clinical trial evaluates the efficacy of sodium hypochlorite (NaOCl), chlorhexidine (CHX), and cold saline as hemostatic agents in partial pulpotomy. The study compares postoperative pain (via VAS scores) and pulp survival (via clinical/radiographic evaluation) at 1, 3, 7 days, 6 months, and 12 months
Interventions
- Drug Sodium Hypochlorite 2,5%
2.5% NaOCl applied for 1 min to exposed pulp for hemostasis, followed by standard pulp capping - Drug Chlorhexidine
2% CHX applied for 1 min to achieve hemostasis, with identical subsequent steps to NaOCl group - Drug Cold Saline
Hemostasis via 4°C saline (1 Min), then standardized pulp capping
Primary outcome measures
- Postoperative Pain [Time frame: 1 week]
- Pulp Survival Rate [Time frame: 12 months]
Secondary outcome measures (1)
- Clinical Success [Time frame: 12 months]
Eligibility criteria
Inclusion criteria
- Permanent teeth with carious pulp exposure (no spontaneous pain).
- Positive vitality test (Endo-Ice).
- No periapical radiolucency.
Exclusion criteria
- Systemic diseases affecting healing.
- Pregnancy.
- Non-vital pulp/necrosis
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Turkey (Türkiye) · 1 center
- Çukurova Üniversitesi Diş Hekimliği Fakültesi — Adana
Identifiers
NCT: NCT07058727 · PP-HemoRCT-2025